Table 1. Sample description.
| N = 94 | ||
|---|---|---|
| Gender, n (%) | ||
| Female | 49 (52,1%) | |
| Male | 45 (47,9%) | |
| Age (years) | ||
| Mean | 5,96 | |
| SD/Min-Max | 3,811/1-18 | |
| Age at T1D diagnosis (years) | ||
| Mean | 5,94 | |
| SD/Min-Max | 2,57/1,08-10,75 | |
| Follow-up of T1D (years) | ||
| Mean | 4,57 | |
| SD/Min-Max | 2,94; 0,08 10,08 | |
| PH of AID n (%) | 3 (3,2%) | |
| AIT | 3 (100%) | |
| FH of AID n (%) | 14 (14,9%) | |
| T1D | 6 (42,86%) | |
| SLE | 3 (21,43%) | |
| CD | 2 (14,29%) | |
| Psoríase e and T1D | 1 (7,14%) | |
| AIT | 2 (14,29%) | |
| HLA screening, n (%) | ||
| Negative | 8 (15,4%) | |
| Positive | 44 (84,6%) | |
| IgA deficiency, n (%) | 1 (1,1%) | |
| Antibodies IgA/IgG at diagnosis, n (%) | ||
| Negative | 90 (95,7%) | |
| Positive | 4 (4,3%) | |
| Antibodies IgA/ IgG (2 years) n (%) | ||
| Not applicable | 15 (16,7%) | |
| Negative | 75 (83,3%) | |
| Antibodies IgA/IgG (5 years) n (%) | ||
| Not applicable | 28 (31,1%) | |
| Negative | 62 (68,9%) | |
| Biopsy histology n (%) | ||
| Number of biopsies | 4 (4,3%) | |
| Positive | 4 (100%) | |
| CD diagnosis n (%) | ||
| Negative | 90 (95,7%) | |
| Positive | 4 (4,3%) | |
AID: autoimmune disease; AIT: autoimmune thyroiditis; CD: celiac disease; FH: family history; PH: past history; SLE: systemic lupus erythematosus.